ENaC channels may inspire new treatments
This discovery is very exciting for the cystic fibrosis community. It means that we may have a new target for potential new therapies for the disease. Perhaps if we could target ENaCs with some type of small molecule or antibody-based drug, we could induce the same kind of protective effect in patients who lack this beneficial ENaC variant. This doesn't mean just reducing symptoms; it could also mean prolonging life, too.